These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 24819127

  • 1. [News of antibiotic resistance among Gram-negative bacilli in Algeria].
    Baba Ahmed-Kazi Tani Z, Arlet G.
    Pathol Biol (Paris); 2014 Jun; 62(3):169-78. PubMed ID: 24819127
    [Abstract] [Full Text] [Related]

  • 2. Carbapenem-resistant Gram-negative bacilli in Canada 2009-10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP).
    Mataseje LF, Bryce E, Roscoe D, Boyd DA, Embree J, Gravel D, Katz K, Kibsey P, Kuhn M, Mounchili A, Simor A, Taylor G, Thomas E, Turgeon N, Mulvey MR, Canadian Nosocomial Infection Surveillance Program.
    J Antimicrob Chemother; 2012 Jun; 67(6):1359-67. PubMed ID: 22398651
    [Abstract] [Full Text] [Related]

  • 3. [Detection of resistance phenotypes in gram-negative bacteria].
    Navarro F, Calvo J, Cantón R, Fernández-Cuenca F, Mirelis B.
    Enferm Infecc Microbiol Clin; 2011 Jun; 29(7):524-34. PubMed ID: 21696863
    [Abstract] [Full Text] [Related]

  • 4. Epidemiology of infections caused by multiresistant gram-negatives: ESBLs, MBLs, panresistant strains.
    Rossolini GM, Mantengoli E, Docquier JD, Musmanno RA, Coratza G.
    New Microbiol; 2007 Jul; 30(3):332-9. PubMed ID: 17802921
    [Abstract] [Full Text] [Related]

  • 5. [The growing problem of antibiotic resistance in clinically relevant Gram-negative bacteria: current situation].
    Martínez-Martínez L, Calvo J.
    Enferm Infecc Microbiol Clin; 2010 Sep; 28 Suppl 2():25-31. PubMed ID: 21130927
    [Abstract] [Full Text] [Related]

  • 6. [Carbapenemases in gram-negative bacteria. Current data and trends of resistance resulting from the work of national reference centres].
    Kaase M.
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Nov; 55(11-12):1401-4. PubMed ID: 23114438
    [Abstract] [Full Text] [Related]

  • 7. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS, Loeb M, Brooks AA.
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [Abstract] [Full Text] [Related]

  • 8. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
    Gür D, Gülay Z, Akan OA, Aktaş Z, Kayacan CB, Cakici O, Eraç B, Gültekin M, Oğünç D, Söyletir G, Unal N, Uysal S.
    Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
    [Abstract] [Full Text] [Related]

  • 9. Drug resistance phenotypes and genotypes in Mexico in representative gram-negative species: Results from the infivar network.
    Garza-González E, Bocanegra-Ibarias P, Bobadilla-Del-Valle M, Ponce-de-León-Garduño LA, Esteban-Kenel V, Silva-Sánchez J, Garza-Ramos U, Barrios-Camacho H, López-Jácome LE, Colin-Castro CA, Franco-Cendejas R, Flores-Treviño S, Morfín-Otero R, Rojas-Larios F, Mena-Ramírez JP, Fong-Camargo MG, Morales-De-la-Peña CT, García-Mendoza L, Choy-Chang EV, Aviles-Benitez LK, Feliciano-Guzmán JM, López-Gutiérrez E, Gil-Veloz M, Barajas-Magallón JM, Aguirre-Burciaga E, López-Moreno LI, Martínez-Villarreal RT, Canizales-Oviedo JL, Cetina-Umaña CM, Romero-Romero D, Bello-Pazos FD, Barlandas-Rendón NRE, Maldonado-Anicacio JY, Bolado-Martínez E, Galindo-Méndez M, Perez-Vicelis T, Alavez-Ramírez N, Méndez-Sotelo BJ, Cabriales-Zavala JF, Nava-Pacheco YC, Moreno-Méndez MI, García-Romo R, Silva-Gamiño AR, Avalos-Aguilera AM, Santiago-Calderón MA, López-García M, Velázquez-Acosta MDC, Cobos-Canul DI, Vázquez-Larios MDR, Ortiz-Porcayo AE, Guerrero-Núñez AE, Valero-Guzmán J, Rosales-García AA, Ostos-Cantú HL, Camacho-Ortiz A.
    PLoS One; 2021 Oct; 16(3):e0248614. PubMed ID: 33730101
    [Abstract] [Full Text] [Related]

  • 10. [Gram-negative bacteriae with resistance to carbapenems].
    Nordmann P.
    Med Sci (Paris); 2010 Nov; 26(11):950-9. PubMed ID: 21106177
    [Abstract] [Full Text] [Related]

  • 11. The current state of multidrug-resistant gram-negative bacilli in North America.
    Nicasio AM, Kuti JL, Nicolau DP.
    Pharmacotherapy; 2008 Feb; 28(2):235-49. PubMed ID: 18225969
    [Abstract] [Full Text] [Related]

  • 12. Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases.
    Shah AA, Hasan F, Ahmed S, Hameed A.
    Res Microbiol; 2004 Feb; 155(6):409-21. PubMed ID: 15249058
    [Abstract] [Full Text] [Related]

  • 13. The emergence and implications of metallo-beta-lactamases in Gram-negative bacteria.
    Walsh TR.
    Clin Microbiol Infect; 2005 Nov; 11 Suppl 6():2-9. PubMed ID: 16209700
    [Abstract] [Full Text] [Related]

  • 14. [Broad-spectrum beta-lactamases in Gram-negative bacteria].
    Sundsfjord A, Simonsen GS, Haldorsen B, Lundblad EW, Samuelsen O.
    Tidsskr Nor Laegeforen; 2008 Dec 04; 128(23):2741-5. PubMed ID: 19079424
    [Abstract] [Full Text] [Related]

  • 15. [Qnr and aac (6')-Ib-cr types quinolone resistance among Enterobacteriaceae isolated in Annaba, Algeria].
    Meradi L, Djahoudi A, Abdi A, Bouchakour M, Perrier Gros Claude JD, Timinouni M.
    Pathol Biol (Paris); 2011 Aug 04; 59(4):e73-8. PubMed ID: 19896287
    [Abstract] [Full Text] [Related]

  • 16. Extended-spectrum cephalosporin-resistant Gram-negative organisms in livestock: an emerging problem for human health?
    Seiffert SN, Hilty M, Perreten V, Endimiani A.
    Drug Resist Updat; 2013 Aug 04; 16(1-2):22-45. PubMed ID: 23395305
    [Abstract] [Full Text] [Related]

  • 17. Trends in multidrug-resistant gram-negative bacilli and the role of prolonged β-lactam infusion in the intensive care unit.
    Guervil DJ, Chau T.
    Crit Care Nurs Q; 2013 Aug 04; 36(4):345-55. PubMed ID: 24002425
    [Abstract] [Full Text] [Related]

  • 18. Metallo-β-lactamases: a last frontier for β-lactams?
    Cornaglia G, Giamarellou H, Rossolini GM.
    Lancet Infect Dis; 2011 May 04; 11(5):381-93. PubMed ID: 21530894
    [Abstract] [Full Text] [Related]

  • 19. [Antibacterial drug resistance in Latin America: consequences for infectious disease control].
    Casellas JM.
    Rev Panam Salud Publica; 2011 Dec 04; 30(6):519-28. PubMed ID: 22358396
    [Abstract] [Full Text] [Related]

  • 20. In vitro susceptibility of characterized β-lactamase-producing Gram-negative bacteria isolated in Japan to ceftazidime-, ceftaroline-, and aztreonam-avibactam combinations.
    Yoshizumi A, Ishii Y, Aoki K, Testa R, Nichols WW, Tateda K.
    J Infect Chemother; 2015 Feb 04; 21(2):148-51. PubMed ID: 25444674
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.